Whitworth Ralph V

DirectorGENZYME CORP (GENZ) · full profile →Form 4 · filed Apr 6, 2011
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 4, 2011Disposed to issuer(D)2K$74.00$176K2K
Apr 4, 2011Option exercise(M)2K$05K
Apr 4, 2011Tender(U)10.6M$74.00$784.9M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 4, 2011Option exercise(M)2K$00
Apr 4, 2011Disposed to issuer(D)7K$51.52$367K0
Apr 4, 2011Disposed to issuer(D)7K$52.66$375K0

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion
U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-11-011386) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about GENZ insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001225208-11-011386"
Ask your agent
Use Arkolith to summarize insider buying and selling at GENZYME CORP
over the last 90 days and cite the filings.